MAIA Biotechnology Inc (MAIA)
3.28
+0.16
(+5.13%)
USD |
NYAM |
May 17, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Net Income (TTM): -23.72M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -23.72M |
| December 31, 2023 | -19.77M |
| September 30, 2023 | -17.66M |
| June 30, 2023 | -17.69M |
| March 31, 2023 | -16.47M |
| Date | Value |
|---|---|
| December 31, 2022 | -15.77M |
| September 30, 2022 | -14.52M |
| June 30, 2022 | -14.81M |
| March 31, 2022 | -14.93M |
| December 31, 2021 | -12.50M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-23.72M
Minimum
Mar 2024
-12.50M
Maximum
Dec 2021
-16.79M
Average
-16.12M
Median
Net Income (TTM) Benchmarks
| Cyclacel Pharmaceuticals Inc | -22.56M |
| Avid Bioservices Inc | -17.68M |
| Oragenics Inc | -20.66M |
| NeuBase Therapeutics Inc | -13.73M |
| Viking Therapeutics Inc | -93.72M |